XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock Class B
Common Stock
Common Stock Class A
Common Stock
Common Stock Class B
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021       170,625,994 9,842,105      
Beginning balance at Dec. 31, 2021 $ 11,031,466     $ 168 $ 12 $ 13,169,118 $ (18,141) $ (2,119,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (1,256,145)             (1,256,145)
Exercises of vested stock options (in shares)       373,793 392,231      
Exercises of vested stock options 22,500         22,500    
Vesting of restricted stock units (in shares)       4,277,266        
Vesting of restricted stock units 0     $ 4   (4)    
Value of equity awards withheld for tax liability (in shares)       (6,250)        
Value of equity awards withheld for tax liability (1,098)         (1,098)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       616,731 (616,731)      
Shares of Class A common stock issued and donated to charity (in shares)       88,408        
Shares of Class A common stock issued and donated to charity 9,541         9,541    
Unrealized gain (loss) on marketable securities (83,049)           (83,049)  
Foreign currency translation (5,587)           (5,587)  
Shares returned from escrow (in shares)       (152,239)        
Shares returned from escrow (387)         (387)    
Shares issued under ESPP (in shares)       534,401        
Shares issued under ESPP 37,065     $ 2   37,063    
Net change in market value of effective foreign currency forward exchange contracts 556           556  
Share of other comprehensive income (loss) from equity method investment (14,940)           (14,940)  
Stock-based compensation 804,845         804,845    
Stock-based compensation - restructuring 14,275         14,275    
Ending balance (in shares) at Dec. 31, 2022       176,358,104 9,617,605      
Ending balance at Dec. 31, 2022 10,559,042     $ 174 $ 12 14,055,853 (121,161) (3,375,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (1,015,441)             (1,015,441)
Exercises of vested stock options (in shares)       238,474 127,982      
Exercises of vested stock options 7,344         7,344    
Vesting of restricted stock units (in shares)       5,939,641        
Vesting of restricted stock units 0     $ 7   (7)    
Value of equity awards withheld for tax liability (in shares)       (38,655)        
Value of equity awards withheld for tax liability (2,565)         (2,565)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       9,745,587 (9,745,587)      
Conversion of shares of Class B common stock into shares of Class A common stock 0     $ 12 $ (12)      
Shares of Class A common stock issued and donated to charity (in shares)       88,408        
Shares of Class A common stock issued and donated to charity 5,346         5,346    
Unrealized gain (loss) on marketable securities $ 99,742           99,742  
Repurchases of shares of Class A common stock including related costs (in shares) (11,300,000)     (11,292,516)        
Repurchases of shares of Class A common stock including related costs $ (674,706)     $ (11)       (674,695)
Foreign currency translation 5,587           5,587  
Shares issued under ESPP (in shares)       906,728        
Shares issued under ESPP 36,496         36,496    
Net change in market value of effective foreign currency forward exchange contracts 898           898  
Share of other comprehensive income (loss) from equity method investment 15,553           15,553  
Stock-based compensation 682,241         682,241    
Stock-based compensation - restructuring $ 13,015         13,015    
Ending balance (in shares) at Dec. 31, 2023 181,945,771 181,945,771 0 181,945,771 0      
Ending balance at Dec. 31, 2023 $ 9,732,552     $ 182 $ 0 14,797,723 619 (5,065,972)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (109,403)             (109,403)
Exercises of vested stock options (in shares)       181,818        
Exercises of vested stock options 4,341         4,341    
Vesting of restricted stock units (in shares)       6,639,672        
Vesting of restricted stock units 0     $ 7   (7)    
Value of equity awards withheld for tax liability (in shares)       (28,006)        
Value of equity awards withheld for tax liability (2,000)         (2,000)    
Shares of Class A common stock issued and donated to charity (in shares)       88,408        
Shares of Class A common stock issued and donated to charity 5,907         5,907    
Unrealized gain (loss) on marketable securities $ 7,332           7,332  
Repurchases of shares of Class A common stock including related costs (in shares) (36,800,000)     (36,848,645)        
Repurchases of shares of Class A common stock including related costs $ (2,346,671)     $ (36)       (2,346,635)
Foreign currency translation 0              
Shares returned from escrow (in shares)       (696)        
Shares returned from escrow (192)         (192)    
Shares issued under ESPP (in shares)       632,375        
Shares issued under ESPP 33,045         33,045    
Net change in market value of effective foreign currency forward exchange contracts (9,986)           (9,986)  
Share of other comprehensive income (loss) from equity method investment 734           734  
Stock-based compensation 634,129         634,129    
Stock-based compensation - restructuring $ 3,178         3,178    
Ending balance (in shares) at Dec. 31, 2024 152,610,697 152,610,697 0 152,610,697        
Ending balance at Dec. 31, 2024 $ 7,952,966     $ 153   $ 15,476,124 $ (1,301) $ (7,522,010)